ICL Group Ltd. has declared a cash dividend of $0.04881 per share, amounting to approximately $63 million. This decision was made by the company's Board of Directors on November 10, 2026. The dividend reflects ICL's commitment to returning value to its shareholders and may influence other companies in the agricultural chemicals sector to consider similar actions.
ICL Group Ltd., classified under the SIC code 2870 for Agricultural Chemicals, operates on the New York Stock Exchange under the ticker symbol ICL. The company is known for its diverse portfolio in the agricultural sector, focusing on innovative solutions for crop nutrition and protection. Recent filings indicate that the company is actively engaging with its shareholders and maintaining transparency in its financial activities.
According to the filing, the dividend payment will be made only to registered shareholders who are entitled to receive at least $2. The record date for this dividend is set for December 2, 2026, with the payment date scheduled for December 16, 2026. Notably, some shareholders will receive their dividends in New Israeli Shekels (NIS), and the amount may vary based on the exchange rate set by the Bank of Israel on December 1, 2026.
This dividend distribution is significant for ICL Group and its shareholders. It may also impact the agricultural chemicals industry as companies assess their financial strategies and shareholder returns. The filing indicates that withholding tax will apply to the dividend, with specific rates for Israeli residents and foreign shareholders, which could affect the net amount received by investors.
Looking ahead, ICL Group's next steps regarding shareholder engagement and financial performance will likely be revealed in future filings. The company continues to focus on its growth and profitability while ensuring that it rewards its shareholders appropriately.
Read Next
Vox Royalty Corp. Reports Strong Q3 2026 Financial Results
Amarc Resources provides operational updates in recent filing
Collective Mining reports interim financial results for Q3 2026
Radiopharm Theranostics discloses director interest changes
PTL Ltd changes trading symbol from PTLE to ZYN on Nasdaq
Central Puerto S.A. Reports Strong Financial Results for 2026








